Multiple Sclerosis

Common IV infusion therapies for management of Multiple Sclerosis:


Multiple sclerosis is a disease that can affect your brain, spinal cord, and the optic nerves in your eyes. It can cause problems with vision, balance, muscle control, and other basic body functions and can last years.  Our highly trained staff can assist to manage your symptoms when your physician orders one of the following therapies.


TYSABRI® (natalizumab):

TYSABRI is for those with relapsing MS. Administered as an infusion once every 28 days, TYSABRI can help you fight for things like slowing the progression of physical disability, reducing formation of new brain lesions, and reducing the number of relapses to improve quality of your life. The infusion usually lasts an hour.  You also must be enrolled in the TOUCH® program.  To learn more, visit their site.

LEMTRADA® (alemtuzumab):

LEMTRADA is a prescription infusion medicine used to treat adults with relapsing multiple sclerosis (MS). It’s generally used in those who have tried 2 or more MS medicines that haven’t worked well enough and is the first relapsing MS medication that is administered in 8 doses over two years, making it convenient for you.  LEMTRADA is given by infusion 5 days in a row. One year later, there is a second round of IV treatments for 3 days in a row.  To learn more, visit their site.


OCREVUS is a prescription medicine used to treat adults with relapsing or primary progressive forms of multiple sclerosis. Hepatitis B virus screening is required before the first dose.  Your first dose of OCREVUS will be given as 2 separate infusions, 2 weeks apart. These will last about 2.5 hours each. Every dose after your first will be given as 1 single infusion 6 months apart, lasting about 3.5 hours. OCREVUS should be given under the close supervision of an experienced healthcare provider.  To learn more, visit their site.